The economic value of anti-IgE in severe persistent, IgE-mediated (allergic) asthma patients:adaptation of INNOVATE to Sweden

Dewilde, Sarah; Turk, F.; Tambour, Magnus; Sandström, Thomas

doi:10.1185/030079906x132389

Public

The economic value of anti-IgE in severe persistent, IgE-mediated (allergic) asthma patients:adaptation of INNOVATE to Sweden

Published in Current Medical Research and Opinion • Aug 3, 2006

Authors:

Sarah Dewilde

F. Turk

Magnus Tambour

Abstract

BACKGROUND: Severe allergic asthma patients may not be controlled even with guideline recommended care, including inhaled corticosteroids, long-acting beta-2 agonists, theophylline, oral steroids and anti-leukotrienes. They experience exacerbations requiring intensive healthcare use and which may be...

Subject

Omalizumab

Medicine

Exacerbation

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!